兽用抗感染药市场 - 增长、趋势、COVID-19 影响和预测 (2023 - 2028)

市场按动物类型、产品类型(抗菌剂、抗病毒剂、抗真菌剂等)、管理模式和地理划分

市场快照

Study Period: 2018 - 2026
Fastest Growing Market: Asia Pacific
Largest Market: North America
CAGR: 4.5 %

Major Players

rd-img

*Disclaimer: Major Players sorted in no particular order

setting-icon

Need a report that reflects how COVID-19 has impacted this market and its growth?

市场概况

致命动物疾病的防治是兽用抗感染药的关键市场指标。某些因素,例如人畜共患病和食源性疾病的增加、宠物拥有量的增加以及动物保健领域的研发活动增加。由于食用受污染的食物和水,在制备、加工过程中接触病原体,或通过与受感染的动物或人类直接接触,人畜共患病和食源性疾病会自然地从动物传播给人类。人畜共患疾病在世界各地相当普遍。美国疾病控制与预防中心 (CDC) 的科学家表示,人类已知的每 10 种传染病中,就有超过 6 种是通过动物传播的,此外,每 4 种新发或新出现的传染病中,就有 3 种是通过动物传播的。所以,显然,这些疾病是世界范围内的主要公共卫生问题。因此,预计人畜共患病负担的增加将影响市场的增长。

报告范围

根据报告的范围,抗感染药包括多种动物保健产品,可防止传染原或生物体传播。这些包括抗菌剂,抗病毒剂,抗真菌剂等。

By Animal Type
Cattle
Poultry
Cats
Dogs
Other Animals
By Product Type
Antibacterial
Antivirals
Antifungals
Others
By Mode of Administration
Oral
Topical
Others
Geography
North America
United States
Canada
Mexico
Europe
France
Germany
United Kingdom
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle-East and Africa
GCC
South Africa
Rest of Middle-East and Africa
South America
Brazil
Argentina
Rest of South America

Report scope can be customized per your requirements. Click here.

主要市场趋势

预计牛细分市场将在预测年份显示出更好的增长

根据动物类型,分为牛、家禽、猫、狗和其他动物。牛细分市场的增长主要归因于世界各地的牛群数量众多以及养牛业占许多国家人民主要收入来源的主导地位。例如,在中国和墨西哥等牲畜数量较多的国家,牛抗感染产品的市场比发达国家要大。根据联合国粮食及农业组织 (FAO) 的数据,全球牛的数量超过 14 亿头,其中很大一部分来自印度、巴西和中国等国家。此外,2019 年, Bimeda 获得 FDA 批准的 OxyMed LA 用于治疗猪和牛的细菌性肠炎。因此,新产品的批准,

Veterinary Anti-infectives Market 1

竞争格局

兽用抗感染药市场的全球参与者有——拜耳公司、勃林格殷格翰公司、Ceva Santé Animale、Elanco、默克公司、Phibro 动物保健公司、Vetoquinol SA、Virbac 和 Zoetis Inc.。

主要玩家

  1. Bayer AG

  2. Boehringer Ingelheim GmbH

  3. Ceva Santé Animale

  4. Elanco

  5. Zoetis Inc.

*Disclaimer: Major Players sorted in no particular order

Veterinary Anti-infectives Market - 1

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Increasing Zoonotic and Foodborne Diseases

      2. 4.2.2 Rising Pet Ownership

      3. 4.2.3 Rising R&D Activities in Animal Healthcare

    3. 4.3 Market Restraints

      1. 4.3.1 Use of Counterfeit Medicines

      2. 4.3.2 Increasing Cost of Veterinary Services

    4. 4.4 Porter's Five Forces Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 By Animal Type

      1. 5.1.1 Cattle

      2. 5.1.2 Poultry

      3. 5.1.3 Cats

      4. 5.1.4 Dogs

      5. 5.1.5 Other Animals

    2. 5.2 By Product Type

      1. 5.2.1 Antibacterial

      2. 5.2.2 Antivirals

      3. 5.2.3 Antifungals

      4. 5.2.4 Others

    3. 5.3 By Mode of Administration

      1. 5.3.1 Oral

      2. 5.3.2 Topical

      3. 5.3.3 Others

    4. 5.4 Geography

      1. 5.4.1 North America

        1. 5.4.1.1 United States

        2. 5.4.1.2 Canada

        3. 5.4.1.3 Mexico

      2. 5.4.2 Europe

        1. 5.4.2.1 France

        2. 5.4.2.2 Germany

        3. 5.4.2.3 United Kingdom

        4. 5.4.2.4 Italy

        5. 5.4.2.5 Spain

        6. 5.4.2.6 Rest of Europe

      3. 5.4.3 Asia-Pacific

        1. 5.4.3.1 China

        2. 5.4.3.2 Japan

        3. 5.4.3.3 India

        4. 5.4.3.4 Australia

        5. 5.4.3.5 South Korea

        6. 5.4.3.6 Rest of Asia-Pacific

      4. 5.4.4 Middle-East and Africa

        1. 5.4.4.1 GCC

        2. 5.4.4.2 South Africa

        3. 5.4.4.3 Rest of Middle-East and Africa

      5. 5.4.5 South America

        1. 5.4.5.1 Brazil

        2. 5.4.5.2 Argentina

        3. 5.4.5.3 Rest of South America

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Bayer AG

      2. 6.1.2 Boehringer Ingelheim GmbH

      3. 6.1.3 Ceva Sante Animale

      4. 6.1.4 Elanco

      5. 6.1.5 Merck & Co Inc.

      6. 6.1.6 Phibro Animal Health Corporation

      7. 6.1.7 Vetoquinol S.A.

      8. 6.1.8 Virbac

      9. 6.1.9 Zoetis Inc.

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies, and Recent Developments
You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

从 2018 年到 2028 年研究了兽用抗感染药市场。

未来 5 年,兽用抗感染药市场的复合年增长率为 4.5%。

亚太地区在 2018 年至 2028 年期间的复合年增长率最高。

北美在 2021 年的份额最高。

Bayer AG、Boehringer Ingelheim GmbH、Ceva Santé Animale、Elanco、Zoetis Inc. 是在兽用抗感染药市场上运营的主要公司。

close-icon
80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!